Yu-Ching Li Selected Research

2-aminofluorene

3/2006	Ketoprofen-inhibited N-acetyltransferase activity and gene expression in human colon tumor cells.
3/2005	N-acetyltransferase is involved in baicalein-induced N-acetylation of 2-aminofluorene and DNA-2-aminofluorene adduct formation in human leukemia HL-60 cells.
9/2003	Aloe-emodin inhibited N-acetylation and DNA adduct of 2-aminofluorene and arylamine N-acetyltransferase gene expression in mouse leukemia L 1210 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Ching Li Research Topics

Disease

6	Neoplasms (Cancer) 03/2010 - 09/2003
3	Leukemia 01/2008 - 09/2003
2	Ganglion Cysts (Ganglion) 03/2010 - 03/2009
1	Dystonia musculorum deformans type 1 01/2018
1	Infections 01/2018
1	Type 2 Diabetes Mellitus (MODY) 10/2017
1	Neoplasm Metastasis (Metastasis) 03/2010
1	Lymphadenopathy 01/2010
1	Pathologic Complete Response 01/2010
1	Lymphoma (Lymphomas) 01/2010
1	Breast Neoplasms (Breast Cancer) 05/2008
1	Colonic Neoplasms (Colon Cancer) 03/2007
1	Aberrant Crypt Foci 03/2006
1	Adenocarcinoma 03/2006
1	Leukemia L1210 09/2003

Drug/Important Bio-Agent (IBA)

3	baicaleinIBA 03/2009 - 03/2005
3	2-aminofluoreneIBA 03/2006 - 09/2003
3	N-acetyltalosaminuronic acid (NAT)IBA 03/2006 - 09/2003
2	CurcuminIBA 03/2010 - 01/2008
2	diallyl disulfide (diallyl disulphide)IBA 03/2007 - 03/2006
2	Arylamine N-AcetyltransferaseIBA 03/2006 - 09/2003
2	Messenger RNA (mRNA)IBA 03/2006 - 09/2003
2	AcetyltransferasesIBA 03/2006 - 03/2005
2	DNA AdductsIBA 03/2006 - 09/2003
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Red Fluorescent ProteinIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2017
1	Drug CombinationsIBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 03/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2009
1	STAT1 Transcription FactorIBA 03/2007
1	Ketoprofen (Orudis)FDA LinkGeneric 03/2006
1	AzoxymethaneIBA 03/2006
1	aloe emodinIBA 09/2003
1	2-aminofluorene-DNA complexIBA 09/2003

Therapy/Procedure

2	Therapeutics 10/2017 - 03/2010
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010
1	Radiotherapy 01/2010
1	Drug Therapy (Chemotherapy) 03/2007